TP53 and breast carcinoma: Compared to mutation-negative women, TP53 mutation carriers were not enriched for a family history of ovarian cancer (9% in mutation carriers vs. 17% in non-carriers, p > 0.05) or for first degree relatives with breast cancer (p > 0.05).